The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
In January 2026, 10x Genomics, Inc. reported preliminary 2025 results showing about US$166.0 million in fourth-quarter ...
Without a clear single news headline driving it today, 10x Genomics (TXG) has drawn attention after recent share price moves, ...
StockStory.org on MSN
10x Genomics (TXG) stock is up, what you need to know
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...
Genomics BioSci & Tech (Genomics) reported consolidated revenue of NT$112 million (US$3.54 million) in December 2025, setting ...
10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...
New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology "The new products we have planned for 2024 will take 10x to ...
The ARK Genomic Revolution ETF offers unique, actively managed exposure to innovative genomics companies, focusing on small- and mid-caps for high-growth potential. ARKG's active management and high ...
Singular Genomics Systems, Inc. has announced the completion of its acquisition by Deerfield Management Company, with the deal priced at $20.00 per share for all outstanding common stock not owned by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback